1
|
Guo S, Zhang L, Wu S, Liu H. Research progress of typical flavonoids in improving insulin resistance. Arch Med Sci Atheroscler Dis 2020; 5:e335-e342. [PMID: 34820547 PMCID: PMC8609372 DOI: 10.5114/amsad.2020.103472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2020] [Accepted: 11/02/2020] [Indexed: 11/17/2022] Open
Abstract
Flavonoids are a large class of compounds that are widely found in many plants, including plants used in Chinese herbal medicines. Previous studies have revealed that flavonoids possess biomedical activities, including antioxidant, anti-cancer, anti-viral, and anti-inflammatory properties. They also have the functions of lowering lipids, lowering blood sugar, and improving insulin resistance. This article selects four typical compounds of flavonoids, namely baicalin, baicalein, quercetin, and rutin, and reviews their effects and mechanisms of action in improving insulin resistance. With a view for future clinical research on flavonoids as antidiabetic drugs, we therefore provide the theoretical basis for the development and application of flavonoids.
Collapse
Affiliation(s)
- Shengnan Guo
- The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, China
| | - Li Zhang
- Tianjin Hedong Shengshi Zhongkang Hospital, China
| | - Shentao Wu
- The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, China
| | - Hongyi Liu
- The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, China
| |
Collapse
|
2
|
Li Y, Li YP, He J, Liu D, Zhang QZ, Li K, Zheng X, Tang GT, Guo Y, Liu Y. The Relationship between Pharmacological Properties and Structure- Activity of Chrysin Derivatives. Mini Rev Med Chem 2019; 19:555-568. [PMID: 29692242 DOI: 10.2174/1389557518666180424094821] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Revised: 09/24/2017] [Accepted: 12/20/2017] [Indexed: 11/22/2022]
Abstract
Chrysin is a natural product of a flavonoid compound. Chemically, chrysin consists of two phenyl rings (A and B) and a heterocyclic ring (C). Biologically, chrysin exerts many different physiological activities. In recent years, with the in-depth development for more active drugs, the synthesis and biological activities of chrysin derivatives have been well studied. Besides, structure-activity relationship of chrysin revealed that the chemical construction meets the critical chemical structural necessities of flavonoids for numerous pharmacological activities. It is generally believed that modified chrysin could be more potent than unmodified chrysin. Different modification in the rings of chrysin could possess various degrees of biological activities. This review aims to summarize the mechanism for the activities of chrysin and its derivatives in different rings. We also explored the relationship between biological function and structure-activity of substituted chrysin derivatives with different functional groups. The influence of chrysin derivatives on the proliferation and apoptosis of cancer cells is also investigated. Development of novel drugs based on the biological functions of chrysin could better improve clinical outcomes of affected population, especially for tumor patients and diabetic patients.
Collapse
Affiliation(s)
- Yang Li
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Yan-Peng Li
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Jun He
- Institute of Chemistry & Chemical Engineering, University of South China, Hengyang 421001, China
| | - Ding Liu
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Qi-Zhi Zhang
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Kang Li
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Xing Zheng
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Guo-Tao Tang
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Yu Guo
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| | - Yunmei Liu
- Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China
| |
Collapse
|
3
|
Xu R, Qi J, Zhan RJ, Zhou GS, Hao B, Ma J, Wei X, Xu AJ, Zhang J. Comparative pharmacokinetics of four active components on normal and diabetic rats after oral administration of Gandi capsules. RSC Adv 2018; 8:6620-6628. [PMID: 35540372 PMCID: PMC9078286 DOI: 10.1039/c7ra11420f] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Revised: 02/26/2018] [Accepted: 01/23/2018] [Indexed: 11/21/2022] Open
Abstract
The Gandi capsule, a famous traditional Chinese medicine (TCM), is a hospital preparation that has been widely used in China for decades for the treatment of diabetes.
Collapse
Affiliation(s)
- Renjie Xu
- Department of Pharmacy
- Xinhua Hospital
- Shanghai 200092
- China
| | - Jia Qi
- Department of Pharmacy
- Xinhua Hospital
- Shanghai 200092
- China
| | - Ruan-Juan Zhan
- Department of Pharmacy
- The First Affiliated Hospital
- Wenzhou Medical University
- Wenzhou
- China
| | - Gui-Sheng Zhou
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization
- National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine
- Nanjing University of Chinese Medicine
- Nanjing 210023
- China
| | - Bin Hao
- School of Pharmacy
- Shanghai Jiao Tong University
- Shanghai 200240
- China
| | - Jing Ma
- Department of Pharmacy
- Xinhua Hospital
- Shanghai 200092
- China
| | - Xin Wei
- Department of Pharmacy
- Xinhua Hospital
- Shanghai 200092
- China
| | - A.-Jing Xu
- Department of Pharmacy
- Xinhua Hospital
- Shanghai 200092
- China
| | - Jian Zhang
- Department of Pharmacy
- Xinhua Hospital
- Shanghai 200092
- China
| |
Collapse
|